Patents by Inventor Antonio Cruz

Antonio Cruz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210144449
    Abstract: Methods and systems to process video data and modify at least the image portion of the video data real time to alter the image content. In one method, providing a multimedia signal to a processing module; identifying a replaceable area of an image taken from the multimedia signal with a context information; matching, by a client server, a user profile with the context information of the replaceable area; fetching, from an advertising database, a selected advertising content, based on the user profile and the context information; placing the selected advertising content on the replaceable area of the image; and providing a customized multimedia signal to a selected channel, wherein the customized multimedia signal comprises the selected advertising content overlapping, at least in part, an original content of the replaceable area of the image.
    Type: Application
    Filed: November 11, 2019
    Publication date: May 13, 2021
    Inventor: José Antonio CRUZ MOYA
  • Patent number: 9642354
    Abstract: The invention discloses a multi-layer cell freezing vial and method of obtention thereof. The method of obtention is a cell freezing and thawing process that avoids the need of incorporating new fresh medium to the thawed cells for the dilution of the cryoprotective agent. This is achieved by the previous freezing of an extra layer of culture medium in addition to the frozen cell solution containing said cryoprotective agent. At the time of thawing, the culture medium and the cell solution mix themselves, turning the concentration of said cryoprotective agent to a non-toxic dilution and achieving the effective exclusion of said cryoprotective agent from the living cells.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: May 9, 2017
    Assignee: Cellulis, S.L.
    Inventors: Roberto Hernan Izquierdo, Natalia Gallot Escobal, Antonio Cruz Pacheco
  • Patent number: 9615570
    Abstract: The present invention is a method of freezing cells comprising the steps of incubating said cells in a solution comprising a cryoprotective agent, concentrating the cells resulting from the previous step withdrawing the eluent essentially free of cells, and freezing the resulting concentrated cells. The cells frozen by the invention's method render a high post-thawing viability, reduce cryoprotectant related toxic events and promote cells life in a suspension state after thawing. The invention also comprises the container comprising the frozen cells.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: April 11, 2017
    Assignee: Cellulis, S.L.
    Inventors: Roberto Hernan Izquierdo, Natalia Gallot Escobal, Antonio Cruz Pacheco
  • Publication number: 20150140656
    Abstract: The present invention is a method of freezing cells comprising the steps of incubating said cells in a solution comprising a cryoprotective agent, concentrating the cells resulting from the previous step withdrawing the eluent essentially free of cells, and freezing the resulting concentrated cells. The cells frozen by the invention's method render a high post-thawing viability, reduce cryoprotectant related toxic events and promote cells life in a suspension state after thawing. The invention also comprises the container comprising the frozen cells.
    Type: Application
    Filed: September 16, 2014
    Publication date: May 21, 2015
    Inventors: Roberto HERNAN IZQUIERDO, Natalia Gallot Escobal, Antonio Cruz Pacheco
  • Publication number: 20140155480
    Abstract: Scyllo-Inositol derivatives represented by structural formula II are described, wherein at least one and not more than five of R1, R2, R3, R4, R5 and R6 is hydroxyl and the other of R1, R2, R3, R4, R5 and R6 are independently alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, sulfoxide, sulfate, sulfonyl, sulfenyl, sulfonate, sulfinyl, ammo, lmmo, azido, thiol, thioalkyl, thioaryl, mtro, cyano, halo, seleno, silyl, silyloxy, silylthio, carboxyl, carbonyl, carbamoyl or carbamide, or pharmaceutically acceptable salts thereof. Said derivatives and compositions comprising the same are useful in the prevention and/or treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence.
    Type: Application
    Filed: February 5, 2014
    Publication date: June 5, 2014
    Applicant: WARATAH PHARMACEUTICALS INC.
    Inventors: Antonio CRUZ, Linda KURDYDYK
  • Publication number: 20140135403
    Abstract: The present invention relates to methods of treating ocular diseases in a subject by administering to the subject a therapeutically effective amount of one or more cyclohexanehexyl derivatives, or salts thereof, or a medicament comprising a cyclohexanehexol derivative and a pharmaceutically acceptable carrier. More specifically, the invention provides a medicament comprising at least one cyclohexanehexyl derivative of formula (III) or (IV) useful in preventing or treating ocular diseases, by modulating the folding, oligomerization or aggregation of amyloid ? in ocular cells. Methods of administration of these medicaments include systemic, transpleural, oral, intravenously, intraarterial, intramuscular, topical, via inhalation, transdermal, subcutaneous, intraperitoneal, gastrointestinal, and directly to the eye or tissues surrounding the eyes. Formulae (III), (IV).
    Type: Application
    Filed: January 16, 2014
    Publication date: May 15, 2014
    Applicant: WARATAH PHARMACEUTICALS INC.
    Inventors: JoAnne McLAURIN, Antonio CRUZ
  • Publication number: 20140004500
    Abstract: The invention discloses a multi-layer cell freezing vial and method of ohtention thereof. The method of obtention is a cell freezing and thawing process that avoids the need of incorporating new fresh medium to the thawed cells for the dilution of the cryoprotective agent. This is achieved by the previous freezing of an extra layer of culture medium in addition to the frozen ceil solution containing said cryoprotective agent. At the time of thawing, the culture medium and the cell solution mix themselves, turning the concentration of said cryoprotective agent to a non-toxic dilution and achieving the effective exclusion of said cryoprotective agent from the living cells.
    Type: Application
    Filed: December 15, 2011
    Publication date: January 2, 2014
    Applicant: ZF BIOTOX, S.L.
    Inventors: Roberto Hernan Izquierdo, Natalia Gallot Escobal, Antonio Cruz Pacheco
  • Patent number: 8287929
    Abstract: Galatinous protein foodstuff and process for its preparation, comprising water, cane sugar, glucose, a protein element, xanthan gum, linseed fibre, vitamins, citrus seed extract, citric acid, malic acid, bifidus and lactobacilli, coloring agent and essence. This product improves human digestion and maximized utilization of the ingested foodstuff. It permits the restoration of the intestinal flora, improves digestive function and activates the immune system when ingested regularly and continuously.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: October 16, 2012
    Inventor: Jośe Antonio Cruz Serrano
  • Publication number: 20110212224
    Abstract: The present invention relates to a mixture of probiotics, prebiotics and nutrient having synergistic symbiotic action and the process of productions thereof. Said mixture comprises at least one probiotic strain selected from lactobacillus, bifidus, streptococcus and/or yeasts; at least one prebiotic basically being inulin is added: a simple carbohydrate being glucose and/or a monosaccharide being sugar, and amines being vitamin E, pyridoxine chlorohydrate, folic acid, vitamin B12 and ascorbic acid, and added nutrients for human consumption being: proteins of animal or vegetable origin with or without the presence of the nine essential amino acids, lipids referentially short-chain, omega and carbohydrates also short-chain for energy release in simple metabolisations.
    Type: Application
    Filed: November 21, 2008
    Publication date: September 1, 2011
    Inventor: Josè Antonio Cruz Serrano
  • Publication number: 20110034379
    Abstract: An embodiment of the invention provided herein is a pharmaceutical composition comprising a gastrin compound having an extended activity upon administration to a subject in comparison with native gastrin. Methods are provided of conjugating portions of the amino acid sequence of gastrin having functional ability to bind to the gastrin/CCK receptor, to various carrier moieties, including the use of amino acid spacer regions, and use of bifunctional cross-linking reagents. Methods of treating a diabetes patient with the compositions are provided.
    Type: Application
    Filed: July 26, 2010
    Publication date: February 10, 2011
    Applicant: Waratah Pharmaceuticals, Inc.
    Inventor: Antonio Cruz
  • Publication number: 20100292157
    Abstract: The invention relates generally to novel compositions and methods comprising a cyclohexanehexol and a secretase inhibitor. The compositions and methods provide beneficial effects, in particular sustained beneficial effects, in the treatment of diseases involving a disorder in protein folding and/or aggregation, and/or amyloid formation, deposition, accumulation, or persistence, such as Alzheimer's disease and related neurodegenerative disorders.
    Type: Application
    Filed: November 22, 2007
    Publication date: November 18, 2010
    Inventor: Antonio Cruz
  • Publication number: 20100256061
    Abstract: The invention relates to compositions and methods for the prevention or treatment of diabetes, comprising a therapeutically effective amount of at least one gastrin compound ie gastrin G1. The gastrin compound provides beneficial effects comprising the control of haemoglobin AIc (HbA1c), fasting blood glucose, glucose levels or insulin levels. The subjects which are treated with the compositions and methods of the invention are selected based on baseline HbA1c levels or based on existing treatment with a glucose lowering agent with or without an insulin sensitivity enhancer, in particular, a metformin with or without a thiazolidinedione. The use of a gastrin compound for decreasing HbA1c levels in a diabetic subject is also proposed.
    Type: Application
    Filed: February 29, 2008
    Publication date: October 7, 2010
    Inventors: Antonio Cruz, Aleksandra Pastrak
  • Patent number: 7803766
    Abstract: The present invention concerns six novel variants of alternative splicing of the CD40 receptor The invention provides a pharmaceutical composition comprising a gastrin compound having an extended activity upon administration to a subject in comparison with native gastrin. Methods are provided of conjugating portions of the amino acid sequence of gastrin having functional ability to bind to the gastrin/CCK receptor, to various carrier moieties, including the use of amino acid spacer regions, and use of bifunctional cross-linking reagents. Methods of treating a diabetes patient with the compositions are provided.
    Type: Grant
    Filed: January 31, 2007
    Date of Patent: September 28, 2010
    Assignee: Warath Pharmaceuticals, Inc
    Inventor: Antonio Cruz
  • Publication number: 20100173960
    Abstract: The invention relates generally to novel compositions and methods comprising one or more cyclohexanehexol and one or more NSAID. The compositions and methods provide beneficial effects in the treatment and prevention of diseases involving a disorder in protein folding and/or aggregation, and/or amyloid formation, deposition, accumulation, or persistence, in particular neurodegenerative diseases.
    Type: Application
    Filed: September 20, 2007
    Publication date: July 8, 2010
    Inventors: Antonio Cruz, Carl Damiani
  • Publication number: 20100168250
    Abstract: The present invention relates to methods of treating ocular diseases in a subject by administering to the subject a therapeutically effective amount of one or more cyclohexanehexol derivatives, or salts thereof, or a medicament comprising a cyclohexanehexol derivative and a pharmaceutically acceptable carrier. More specifically, the invention provides a medicament comprising at least one cyclohexanehexol derivative of formula (III) or (IV) useful in preventing or treating ocular diseases, by modulating the folding, oligomerization or aggregation of amyloid ? in ocular cells. Methods of administration of these medicaments include systemic, transpleural, oral, intravenously, intraarterial, intramuscular, topical, via inhalation, transdermal, subcutaneous, intraperitoneal, gastrointestinal, and directly to the eye or tissues surrounding the eyes.
    Type: Application
    Filed: April 11, 2008
    Publication date: July 1, 2010
    Inventor: Antonio Cruz
  • Publication number: 20100159073
    Abstract: Galatinous protein foodstuff and process for its preparation, comprising water, cane sugar, glucose, a protein element, xanthan gum, linseed fibre, vitamins, citrus seed extract, citric acid, malic acid, bifidus and lactobacilli, colouring agent and essence. This product improves human digestion and maximized utilization of the ingested foodstuff. It permits the restoration of the intestinal flora, improves digestive function and activates the immune system when ingested regularly and continuously.
    Type: Application
    Filed: May 26, 2006
    Publication date: June 24, 2010
    Inventor: José Antonio Cruz Serrano
  • Publication number: 20100144613
    Abstract: The invention relates to compositions, conjugates, and methods for the prevention and/or treatment of a condition and/or disease comprising a therapeutically effective amount of a DPP-IV inhibitor and a gastrin compound. The combination of a DPP-IV inhibitor and a gastrin compound provides beneficial effects, in particular sustained beneficial effects, in the prevention and/or treatment of conditions and/or diseases for which either a DPP-IV inhibitor or a gastrin compound have been demonstrated to have a therapeutic effect, including but not limited to diabetes, hypertension, chronic heart failure, fluid retentive states, obesity, metabolic syndrome and related diseases and disorders. Combinations of a DPP-IV inhibitor and a gastrin compound can be selected to provide unexpectedly additive effects or synergistic effects.
    Type: Application
    Filed: October 6, 2006
    Publication date: June 10, 2010
    Inventor: Antonio Cruz
  • Patent number: 7713456
    Abstract: Processing a die that has an edge and a substrate upon which a layer of moisture permeable material is disposed. The moisture permeable material extends to the edge of the die. One embodiment comprises interrupting the layer of moisture permeable material to form a gap at a boundary near the edge, thereby to substantially block movement of moisture through the gap of the moisture permeable material.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: May 11, 2010
    Assignee: Hewlett-Packard Development Compnay, L.P.
    Inventors: Simon Dodd, Sean P. McClelland, Colby Van Vooren, Terry E. McMahon, Antonio Cruz-Uribe
  • Patent number: D691024
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: October 8, 2013
    Assignee: Orica Australia Pty
    Inventors: Dragomir Stanic, Miguel Antonio Cruz Mojica
  • Patent number: D691460
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: October 15, 2013
    Assignee: Orica Australia Pty Ltd
    Inventors: Dragomir Stanic, Miguel Antonio Cruz Mojica